Rosanna Botta

1.4k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Rosanna Botta is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Rosanna Botta has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Rosanna Botta's work include Acute Myeloid Leukemia Research (4 papers), MicroRNA in disease regulation (3 papers) and Biomedical Ethics and Regulation (2 papers). Rosanna Botta is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), MicroRNA in disease regulation (3 papers) and Biomedical Ethics and Regulation (2 papers). Rosanna Botta collaborates with scholars based in Italy, United States and Japan. Rosanna Botta's co-authors include C Peschle, M Valtieri, Elvira Pelosi, Valentina Lulli, Désirée Bonci, Ornella Morsilli, Carlo M. Croce, Francesco Facchiano, Nadia Felli and Antonio Sorrentino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular and Cellular Biology.

In The Last Decade

Rosanna Botta

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

2005 606 citations Nadia Felli, Laura Fontana et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosanna Botta Italy	8	860	576	197	194	99	13	1.1k
B. Masella Italy	12	890 1.0×	282 0.5×	381 1.9×	248 1.3×	233 2.4×	14	1.3k
Hirono Iriuchishima Japan	6	379 0.4×	263 0.5×	394 2.0×	158 0.8×	145 1.5×	18	785
Paul Takam Kamga Italy	16	610 0.7×	320 0.6×	133 0.7×	297 1.5×	149 1.5×	34	966
K Kluge Germany	5	660 0.8×	159 0.3×	77 0.4×	234 1.2×	75 0.8×	7	902
Yasuhiko Miyata Japan	15	702 0.8×	142 0.2×	379 1.9×	209 1.1×	172 1.7×	31	1.2k
Adam D. Durbin United States	18	1.1k 1.3×	374 0.6×	101 0.5×	55 0.3×	93 0.9×	38	1.6k
J E Murphy-Ullrich United States	10	550 0.6×	215 0.4×	113 0.6×	64 0.3×	73 0.7×	16	948
Rob Dee Netherlands	9	400 0.5×	147 0.3×	480 2.4×	221 1.1×	105 1.1×	11	961
Vionnie W.C. Yu United States	13	571 0.7×	160 0.3×	419 2.1×	120 0.6×	308 3.1×	22	1.0k
Jason Levine United States	7	732 0.9×	184 0.3×	582 3.0×	125 0.6×	157 1.6×	20	1.2k

Countries citing papers authored by Rosanna Botta

Since Specialization

Citations

This map shows the geographic impact of Rosanna Botta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosanna Botta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosanna Botta more than expected).

Fields of papers citing papers by Rosanna Botta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosanna Botta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosanna Botta. The network helps show where Rosanna Botta may publish in the future.

Co-authorship network of co-authors of Rosanna Botta

This figure shows the co-authorship network connecting the top 25 collaborators of Rosanna Botta. A scholar is included among the top collaborators of Rosanna Botta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosanna Botta. Rosanna Botta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Zhang, Qianru, Rosanna Botta, Ying Xu, James Cheng‐Chung Wei, & Tao‐Hsin Tung. (2025). Risk of new-onset dementia following COVID-19 infection: a systematic review and meta-analysis. Age and Ageing. 54(3). 5 indexed citations

2.

Bellino, Stefania, Anna La Salvia, Maria Francesca Cometa, & Rosanna Botta. (2023). Cell-based medicinal products approved in the European Union: current evidence and perspectives. Frontiers in Pharmacology. 14. 1200808–1200808. 16 indexed citations

3.

Botta, Rosanna & Giovanni Migliaccio. (2011). Cell-Based Treatments: Advanced Therapies and Transplants. Transplantation Proceedings. 43(1). 338–340. 2 indexed citations

4.

Felli, Nadia, Laura Fontana, Elvira Pelosi, et al.. (2005). MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proceedings of the National Academy of Sciences. 102(50). 18081–18086. 606 indexed citations breakdown →

5.

Felli, Nadia, Laura Fontana, Elvira Pelosi, et al.. (2005). MicroRNAs 221 and 222 Inhibit Normal Erythropoiesis and Erythroleukemic Cell Growth Via Kit Receptor Downmodulation.. Blood. 106(11). 830–830. 23 indexed citations

6.

Felli, Nadia, Elvira Pelosi, Rosanna Botta, et al.. (2005). Lineage-Specific Expression and Functional Relevance of MicroRNA Genes in Normal Hematopoiesis.. Blood. 106(11). 2263–2263. 2 indexed citations

7.

Botta, Rosanna, Erhe Gao, Giorgio Stassi, et al.. (2004). Heart infarct in NOD‐SCID mice: Therapeutic vasculogenesis by transplantation of human CD34 ⁺ cells and low dose CD34 ⁺ KDR ⁺ cells. The FASEB Journal. 18(12). 1392–1394. 84 indexed citations

8.

Pelosi, Elvira, M Valtieri, Simona Coppola, et al.. (2002). Identification of the hemangioblast in postnatal life. Blood. 100(9). 3203–3208. 210 indexed citations

9.

Grignani, F, M Valtieri, Marco Gabbianelli, et al.. (2000). PML/RARα fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood. 96(4). 1531–1537. 67 indexed citations

10.

Grignani, F, M Valtieri, Marco Gabbianelli, et al.. (2000). PML/RARα fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood. 96(4). 1531–1537. 5 indexed citations

11.

Valtieri, M, Angelo Tocci, Marco Gabbianelli, et al.. (1998). Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.. PubMed. 58(3). 562–9. 48 indexed citations

12.

Botta, Rosanna & Bianca Gustavino. (1997). Relationship between chromatin bridges in anaphase and chromosomal aberrations induced by TMP+UVA (365 nm) in CHO cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 374(2). 253–259. 1 indexed citations

13.

Condorelli, Gianluigi, Angelo Tocci, Rosanna Botta, et al.. (1997). Ectopic TAL-1/SCL Expression in Phenotypically Normal or Leukemic Myeloid Precursors: Proliferative and Antiapoptotic Effects Coupled with a Differentiation Blockade. Molecular and Cellular Biology. 17(5). 2954–2969. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact